Natural History and Factors Associated with Early and Delayed Mortality in HIV-Infected Patients Treated of Tuberculosis under Directly Observed Treatment Short-Course Strategy: A Prospective Cohort Study in India
Open Access
- 18 December 2012
- journal article
- research article
- Published by Hindawi Limited in Interdisciplinary Perspectives on Infectious Diseases
- Vol. 2012, 1-9
- https://doi.org/10.1155/2012/502012
Abstract
Despite the impressive global results of DOTS in India, the effectiveness of DOTS for the treatment of tuberculosis in HIV-infected patients is not well known. This is an observational prospective cohort study performed in Anantapur District, Andhra Pradesh, India. The study included 1000 DOTS antituberculosis treatment (ATT) episodes and 840 person-years. CD4 lymphocyte count was below 200 cells/mm3in 77% of the cases, and 21% were retreatments. Two thirds were presented with extrapulmonary tuberculosis, and the most common form of extrapulmonary tuberculosis was tuberculous meningitis followed by pleuritis, abdominal tuberculosis, and lymphadenitis. Cumulative incidence of mortality was 16%, 26%, 39%, and 46% at 1, 3, 12, and 24 months, respectively. Factors associated with three-month (early) mortality were being homeless, having low CD4+ lymphocyte count, having tuberculous meningitis, belonging to a socially disadvantaged community, having more than 35 years, and being on an antiretroviral therapy at the moment of initiating the ATT. Factors associated with delayed mortality were having low CD4+ lymphocyte count, belonging to a socially disadvantaged community, receiving a category II ATT because of a previous episode of ATT and having acid fast bacilli in sputum before the ATT initiation. These findings indicate that there is an urgent need to improve the treatment of tuberculosis in HIV-infected patients in India.Keywords
This publication has 26 references indexed in Scilit:
- Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in IndiaTuberculosis Research and Treatment, 2012
- Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in IndiaInterdisciplinary Perspectives on Infectious Diseases, 2012
- Outcomes of TB Treatment by HIV Status in National Recording Systems in Brazil, 2003–2008PLOS ONE, 2012
- Connecting the DOTS: Spectre of a public health iatrogenesis?Indian Journal of Community Medicine, 2012
- HIV and Tuberculosis: a Deadly Human SyndemicClinical Microbiology Reviews, 2011
- The Effect of Tuberculosis on Mortality in HIV Positive People: A Meta-AnalysisPLOS ONE, 2010
- Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian populationBMC Public Health, 2010
- Risk Factors for Treatment Default among Re-Treatment Tuberculosis Patients in India, 2006PLOS ONE, 2010
- High Mortality among Patients with AIDS Who Received a Diagnosis of Tuberculosis in the First 3 Months of Antiretroviral TherapyClinical Infectious Diseases, 2009
- HIV-Associated TB in An Giang Province, Vietnam, 2001–2004: Epidemiology and TB Treatment OutcomesPLOS ONE, 2007